why choose us

First received: July 12, 2023

Clinical Trial: A Study of MK-5720 in Participants With Schizophrenia (MK-5720-001)

Study Status: Completed

Recruit Status: RECRUITING

Condition: Schizophrenia

Study Type: INTERVENTIONAL


Official Title: A Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of the Long-Acting Injectable of MK-5720 in Participants With Schizophrenia

Brief Summary: The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics (PK) of single ascending intramuscular doses of MK-5720, and the safety and tolerability of multiple once-daily oral doses of MK-8189, in participants with schizophrenia.The primary study hypothesis is that the administration of MK-5720 is safe and well tolerated.

Read more